Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | MGLL | Q99685 | 3/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | ESR1 | P03372 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2473955 | 1.00 | ALDH1A1 (0.33) | ALDH1A1GLAMGLLKDM4EEPHX2 | |
| SCHEMBL2480035 | 0.89 | EPHX2 (0.32) | MGLLEPHX2 | |
| SCHEMBL2480037 | 0.89 | EPHX2 (0.32) | MGLLEPHX2 | |
| SCHEMBL2477699 | 0.87 | EPHX2 (0.41) | EPHX2TDP1 | |
| SCHEMBL2477700 | 0.87 | EPHX2 (0.41) | EPHX2TDP1 | |
| SCHEMBL2480359 | 0.85 | MGLL (0.38) | MGLLTDP1ESR1 | |
| SCHEMBL2480356 | 0.85 | MGLL (0.38) | MGLLTDP1ESR1 | |
| SCHEMBL2672582 | 0.81 | MGLL (0.38) | ALDH1A1GLAMGLLKDM4E | |
| SCHEMBL2672583 | 0.81 | MGLL (0.38) | ALDH1A1GLAMGLLKDM4E | |
| SCHEMBL2672579 | 0.81 | MGLL (0.38) | ALDH1A1GLAMGLLKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2374794-A1 | CYCLIC AMINE COMPOUNDS | Daiichi Sankyo Company, Limited (JP) | 2011-10-12 | — | — | EP | disclosed |
| EP-2374788-A1 | INDANYL COMPOUNDS | Daiichi Sankyo Company, Limited (JP) | 2011-10-12 | — | — | EP | disclosed |